Physician

Slobodan M Stanisic, M.D.

According to 2025 Medicare claims, Slobodan Stanisic, M.D. (NPI: 1740276823) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (NPI: 1891065256; TIN: 452681845) and primary practice location at 45255-4231. Stanisic is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Stanisic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 651 traditional Medicare patients, billed 198,081 HCPCS/CPT codes, and received $3,248,548 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,244 prescription claims across 267 beneficiaries totaling $2,964,752 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 6 records totaling $149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,806,805 to $3,248,548. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $963,858 to $2,964,752. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	340	162,991	$1,806,805
2016	407	174,785	$2,199,088
2017	427	155,709	$2,217,981
2018	517	116,776	$2,000,369
2019	547	165,165	$2,547,337
2020	530	228,958	$3,479,954
2021	529	191,775	$3,610,406
2022	503	141,757	$3,603,726
2023	650	192,199	$3,085,278
2024	651	198,081	$3,248,548

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	202	1,298	$963,858
2016	196	1,326	$1,472,592
2017	190	1,362	$2,078,686
2018	220	1,470	$2,774,571
2019	236	1,608	$3,621,602
2020	247	1,951	$4,820,532
2021	263	1,817	$3,194,442
2022	232	1,169	$1,643,341
2023	242	1,178	$2,271,586
2024	267	1,244	$2,964,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	34	251	$41,031
2016	12	138	$23,448
2017	N/R	11	$814
2018	N/R	11	$2,983
2019	N/R	N/R	N/R
2020	N/R	52	$5,542
2021	N/R	11	$1,643
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$2,039

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	159	588	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	90	229	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	413	824	$86
96372	Injection of drug or substance under skin or into muscle	86	415	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	437	1,623	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	22	578	$448,529
Calquence	Acalabrutinib Maleate	18	540	$266,491
Jakafi	Ruxolitinib Phosphate	13	390	$259,856
Imbruvica	Ibrutinib	16	458	$233,205
Verzenio	Abemaciclib	14	392	$221,338

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,039

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$149	Blueprint Medicines Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Slobodan M. Stanisic, M.D.?

Tedicare shows public-source Medicare data for Slobodan M. Stanisic, M.D. (NPI 1740276823), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Slobodan M. Stanisic, M.D. have ACO affiliation data?

Slobodan M. Stanisic, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Slobodan M. Stanisic, M.D.?

Slobodan M. Stanisic, M.D. is linked to CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (billing NPI 1891065256) in the available physician profile data.

Does Slobodan M. Stanisic, M.D. have Open Payments data?

Slobodan M. Stanisic, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.